Others implemented mandatory counseling requirements
For individuals managing conditions such as blood vessel disease, diabetes, or metabolic concerns, consistent dosing is especially important for maintaining stable blood sugar levels and reducing the risk of fluctuations such as low blood sugar
doi:10.1074/jbc.273.51.33905 58
Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, and Aetna's 6947-C policy covers that use on its own criteria: "an apnea-hypopnea index (AHI) of at least 15 events per hour on polysomnography or home sleep apnea test" plus a current BMI of 30 or higher
This is significant because many patients on tirzepatide dose escalation schedules end up at higher doses that cost more on other platforms
Gastrointestinal side effects affect up to 25% of GLP-1 users, with nausea and stomach pain being the most frequently reported complaints during the first weeks of treatment